Anebulo Pharmaceuticals, Inc. (ANEB)

Anebulo Pharmaceuticals will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Market Cap	n/a
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Dividend Yield	n/a

Trading Day	n/a
Last Price	n/a
Previous Close	n/a
Change ($)	n/a
Change (%)	n/a
Day's Open	n/a
Day's Range	n/a
Day's Volume	n/a
52-Week Range	n/a

News

Anebulo Pharmaceuticals IPO Registration Document (S-1)

Anebulo Pharmaceuticals, Inc. has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC

About ANEB

Anebulo Pharmaceuticals is a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Our lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. There is no approved medical treatment currently available to specifically alleviate the symptoms of cannabinoid ov... [Read more...]

Industry Pharmaceutical Preparations	IPO Date Pending
CEO Daniel Schneeberger, M.D.	Employees 2
Stock Exchange NASDAQ	Ticker Symbol ANEB

Full Company Profile